1.4 Patient Monitoring Setup, Defibrillator Pads & Pre-Procedural CIED Interrogation

1.4 Patient Monitoring Setup, Defibrillator Pads & Pre-Procedural CIED Interrogation

High-fidelity electrophysiological recording, continuous hemodynamic surveillance, and meticulous management of pre-existing cardiac implantable electronic devices (CIEDs) are critical prerequisites for any invasive electrophysiology procedure. Inadvertent misplacement of surface ECG leads, unrecognized arterial line damping, improper defibrillator pad vectors, or unmanaged electromagnetic interference (EMI) can severely compromise diagnostic accuracy and patient survival.

---

12-Lead Surface ECG Setup & Mason-Likar Modifications

Precise 12-lead surface electrocardiographic monitoring is required throughout electrophysiology studies to diagnose arrhythmias, identify pace-mapping sites, recognize bundle branch blocks, and monitor ischemic ST-segment shifts.

The Mason-Likar Lead Modification

Standard 12-lead ECG lead placement positions the four limb electrodes on the distal wrists and ankles. In the EP laboratory, extremity electrode placement is impractical because patient arm movement, arterial line wrist boards, intravenous lines, and femoral sterile drapes generate severe motion artifacts. Furthermore, limb lead wires would cross the sterile field.

• Torso Repositioning:
  • Right Arm (RA): Infraclavicular fossa, medial to the right deltoid muscle border, 2 cm below the clavicle.
  • Left Arm (LA): Infraclavicular fossa, medial to the left deltoid muscle border, 2 cm below the clavicle.
  • Right Leg (RL): Right lower quadrant of the abdomen, anterior superior iliac spine, or lower right costal margin (serves as electrical ground/reference).
  • Left Leg (LL): Left lower quadrant of the abdomen, anterior superior iliac spine, or lower left costal margin.
• Electrophysiological Vector Alterations: Shifting limb leads to the torso changes the electrical volume conductor geometry, introducing predictable ECG alterations that must be recognized by the RCES specialist:
  • Rightward Frontal Axis Shift: The QRS frontal axis shifts rightward, typically by +15° to +35°.
  • Voltage Variations: QRS amplitude typically increases in limb leads II, III, and aVF, and decreases in lead I.
  • Pseudo-Infarction Pattern: Small, narrow "pseudo-Q waves" or loss of R-wave amplitude frequently emerge in the inferior leads (II, III, aVF), along with slight ST-segment flattening. Clinicians must recognize that these are benign positional artifacts and do not represent acute inferior wall myocardial infarction.

Precordial Lead Placement & Skin Preparation

• Precordial Electrodes (V1 through V6):
  • V1: 4th intercostal space (ICS) at the right sternal border.
  • V2: 4th ICS at the left sternal border.
  • V3: Midway between V2 and V4 on a diagonal line.
  • V4: 5th ICS in the left midclavicular line.
  • V5: 5th ICS in the left anterior axillary line (horizontal level with V4).
  • V6: 5th ICS in the left midaxillary line (horizontal level with V4 and V5).
• Skin Preparation & Impedance Targets: Excessive thoracic hair must be clipped (not shaved with razors, which creates micro-abrasions that elevate infection risk). The skin must be cleaned with alcohol to strip epidermal oils, followed by gentle abrasive skin prep to remove the dead stratum corneum layer. The target inter-electrode impedance is < 5,000 ohms (< 5 kΩ). Low skin-electrode impedance maximizes the Common-Mode Rejection Ratio (CMRR) of the recording system's differential amplifiers, suppressing 60-Hz alternating current (AC) powerline noise and baseline wander.

---

Multi-Parameter Physiological & Hemodynamic Monitoring

Continuous hemodynamic monitoring provides real-time detection of vagal reactions, anesthetic depression, hypovolemia, and acute pericardial tamponade.

Continuous Pulse Oximetry (SpO2)

• Uses dual-wavelength photoplethysmography (660 nm red light absorbed by deoxygenated hemoglobin; 940 nm infrared light absorbed by oxygenated hemoglobin). The probe should be placed on a finger contralateral to the non-invasive blood pressure cuff or arterial line.
• Limitations: Peripheral vasoconstriction, severe hypothermia, intravenous dyes (methylene blue causes false drops in SpO2 to ~85%), and radiofrequency electrosurgical noise.

Non-Invasive Blood Pressure (NIBP)

• Oscillometric blood pressure cuffs must be sized appropriately (bladder width ~40% of upper arm circumference, length ~80%). Cycling intervals are set to every 3 to 5 minutes during baseline sedation, and accelerated to every 1 to 2 minutes during transseptal puncture, rapid ventricular pacing, or arrhythmia induction.

Invasive Arterial Line Setup & Transducer Physics

An indwelling arterial line (typically 20-gauge in the radial or femoral artery) is standard during complex ablation (AF, VT) or in patients with severe ventricular dysfunction.

• Zeroing & Leveling: The pressure transducer must be leveled precisely at the phlebostatic axis—the intersection of the 4th intercostal space and the mid-axillary line, corresponding anatomically to the level of the right and left atria. Leveling the transducer too high results in falsely low pressure readings (hydrostatic error of ~2 mmHg per inch of elevation); leveling too low produces falsely high readings.
• Dynamic Frequency Response & Square-Wave Flush Test:
  • Pulling and rapidly releasing the fast-flush valve introduces a 300 mmHg pressure transient into the non-compliant fluid-filled tubing.
  • Normal Dynamic Response: The flush produces a vertical square wave followed by 1 to 2 rapid oscillations before resuming a crisp arterial waveform with a distinct dicrotic notch.
  • Overdamped Waveform: Characterized by a slurred upstroke, absent dicrotic notch, falsely low systolic pressure, and falsely high diastolic pressure. Caused by compliant tubing, air bubbles in the transducer, blood clots at the catheter tip, or arterial spasm.
  • Underdamped Waveform (Resonance): Characterized by excessive ringing (> 3–4 oscillations after flush), high narrow systolic spikes, falsely high systolic pressure (systolic overshoot), and falsely low diastolic pressure. Caused by excessive tubing length, loose stopcock connections, or catheter whip.

---

Defibrillation Pad Positioning & Biophysics

External defibrillator pads serve two distinct roles: immediate transcutaneous pacing for severe bradycardia and high-energy defibrillation/cardioversion for emergent tachyarrhythmias.

Biophysics of Defibrillation Vectors

Successful termination of atrial fibrillation, ventricular tachycardia, or ventricular fibrillation requires delivering an adequate current density (amperes per square centimeter) through the critical mass of fibrillating myocardium. Transthoracic impedance (TTI) in adults typically averages 70 to 80 ohms.

Anterior-Lateral (AL) versus Anterior-Posterior (AP) Placement

• Anterior-Lateral (AL / Sternum-Apex):
  • Anterior Pad: Right infraclavicular region, lateral to the sternum and below the clavicle.
  • Lateral Pad: Left mid-to-anterior axillary line at the 5th–6th intercostal space, centered over the cardiac apex.
  • Clinical Role: Standard configuration for rapid ventricular defibrillation during CPR and general emergency response.
• Anterior-Posterior (AP / Sternum-Infrascapular):
  • Anterior Pad: Placed over the middle-to-lower sternum or left parasternal region (4th intercostal space).
  • Posterior Pad: Placed in the left infrascapular or interscapular region of the back, to the left of the thoracic spine.
  • Biophysical Superiority for Atrial Arrhythmias: The anterior-posterior vector directs current perpendicularly through the thoracic cavity, traversing directly across the left and right atria. Multiple randomized trials have demonstrated that AP placement achieves significantly lower defibrillation thresholds (DFT) and higher first-shock cardioversion success rates for atrial fibrillation and typical atrial flutter compared to AL placement.

Defibrillator Pad Clearance from CIED Generators

• The 8–10 cm Rule: External defibrillator therapy pads must be positioned at least 8 to 10 cm (3 to 4 inches) away from any implanted pacemaker or ICD pulse generator.
• Mechanism of CIED Injury: High-voltage defibrillation energy delivered directly over or adjacent to a pulse generator can couple capacitively into the transvenous leads (acting as an electrical antenna). The current is channeled directly down the lead conductor to the myocardial-electrode interface, causing:
  1. Endocardial thermal coagulation burns and acute tissue necrosis.
  2. Severe, acute elevation of pacing capture thresholds or permanent exit block.
  3. Permanent fusion of internal magnetic reed switches.
  4. Dielectric breakdown of CMOS circuitry, forcing the device into an unprogrammable Power-On Reset (POR) or backup safety core mode.

---

Pre-Procedural CIED Baseline Interrogation Protocol

Every patient with a permanent pacemaker, transvenous ICD, subcutaneous ICD (S-ICD), or cardiac resynchronization therapy device (CRT-P/CRT-D) must undergo a comprehensive pre-procedural interrogation prior to vascular access.

Systematic Interrogation Checklist

1. Battery Status & Longevity:
   • Record battery cell voltage and internal cell impedance.
   • Verify absence of Elective Replacement Indicator (ERI), Recommended Replacement Time (RRT), or End of Life (EOL / EOS). A device functioning at or near ERI has depleted power reserves; high-current drain during RF ablation or electrosurgical noise may trigger an immediate device reset or failure to deliver therapies.
2. Programmed Operating Parameters:
   • Document programmed pacing mode (e.g., DDD, DDDR, VVI), Lower Rate Limit (LRL), Upper Tracking Rate (UTR), Upper Sensor Rate (USR), paced/sensed AV delays, and rate-adaptive sensor status (accelerometer, minute ventilation).
3. Underlying Intrinsic Rhythm & Pacing Dependency:
   • Momentarily program the pacing rate down to 30–40 bpm (or view intrinsic telemetry) to determine the patient's underlying rhythm.
   • Definition of Pacemaker Dependency: A patient is classified as pacemaker-dependent if they exhibit complete AV block with no escape rhythm, severe sinus arrest/asystole upon pacing reduction, or immediate symptomatic hemodynamic collapse when pacing ceases. Dependent patients require continuous backup pacing throughout the procedure.
4. Electrical Lead Telemetry:
   • Lead Impedance: Normal clinical range is 300 to 1,000 ohms (Ω).
     • Insulation Breach (Short Circuit): Impedance drops acutely < 200 to 300 Ω. Breakdown of outer silicone or polyurethane insulation allows current to leak into surrounding blood and tissue, rapidly draining the battery and causing failure to capture.
     • Conductor Fracture or Loose Set Screw (Open Circuit): Impedance spikes acutely > 1,500 to 2,000 Ω. A physical break in the conductor coil or a loose connector block set screw interrupts current delivery, resulting in an open circuit, loss of capture, and loss of sensing.
   • Intrinsic Sensing Amplitudes: Sensed electrogram voltages generated by native myocardial depolarization:
     • Atrial P-wave Amplitude: Target > 1.5 to 2.0 mV.
     • Ventricular R-wave Amplitude: Target > 5.0 mV (ideally > 8–10 mV).
     • Low sensing amplitudes predispose the device to undersensing, leading to asynchronous pacing that can fire on vulnerable T-waves (R-on-T phenomenon triggering VF).
   • Pacing Capture Thresholds: The minimum electrical output (volts at a specified pulse duration) that consistently depolarizes the myocardium:
     • Acute Implant Threshold: Typically < 1.0 V at 0.5 ms pulse width.
     • Chronic Lead Threshold: Typically < 1.5 V at 0.5 ms pulse width.
     • Output safety margins are programmed at least 2 times voltage threshold (or 3 times in dependent patients).

---

Intra-Procedural EMI Mitigation & Clinical Magnet Responses

Electromagnetic interference (EMI) generated by radiofrequency (RF) ablation catheters (450–550 kHz) and monopolar electrosurgical units (electrocautery, 300 kHz–2 MHz) poses catastrophic hazards to CIED patients.

Clinical Hazards of EMI

• Inappropriate ICD Shocks: High-frequency electrical noise coupled onto ventricular sensing leads is interpreted by the ICD microprocessor as ventricular fibrillation, triggering inappropriate high-voltage shocks (35–40 joules) or rapid antitachycardia pacing (ATP) into a conscious patient, which can induce true ventricular fibrillation.
• Inhibition of Pacing in Pacemaker-Dependent Patients: EMI oversensed on pacing leads mimics intrinsic P-waves or R-waves, causing the pulse generator to inhibit pacing output. In a pacemaker-dependent patient, this results in immediate asystole and circulatory arrest.
• Rate-Adaptive Sensor Overdrive: EMI or physical vibration can activate minute ventilation or accelerometer sensors, driving pacing rates to the programmed Upper Sensor Rate (130–150 bpm).

Device Management Strategies during Procedures

1. Electronic Programmer Deactivation (The Gold Standard):
   • For ICDs: Turn tachyarrhythmia detection "OFF" via the device programmer. If the patient is pacemaker-dependent, reprogram the pacing mode to an asynchronous mode (VOO or DOO at 80–90 bpm) to guarantee continuous pacing during RF application.
   • For Pacemakers: In pacemaker-dependent patients, reprogram to asynchronous VOO or DOO mode at 80–90 bpm, and disable rate-responsive sensors.
2. Clinical Magnet Application:
   • When an electronic programmer is not immediately available or during brief electrosurgery, a clinical donut or ring magnet can be positioned directly over the pulse generator.
   • Pacemaker Magnet Response: A magnet activates an internal reed switch or Hall-effect sensor, forcing the pacemaker into an asynchronous pacing mode (DOO or VOO) at a fixed, manufacturer-specific magnet rate. Sensing is completely disabled, preventing EMI-induced inhibition.
   • ICD Magnet Response: Applying a magnet over a transvenous or subcutaneous ICD suspends tachyarrhythmia detection and shock therapies WITHOUT altering bradycardia pacing. The bradycardia pacing mode and rate remain completely unchanged. Crucial Pearl: A magnet will NOT convert an ICD to asynchronous pacing; if an ICD patient is pacemaker-dependent, a magnet will not prevent EMI-induced pacing inhibition. The ICD must be reprogrammed via a programmer.